Modrzejewska Monika, Bosy-Gąsior Wiktoria
2nd Department of Ophthalmology, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.
Scientific Association of Students 2nd Department of Ophthalmology, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.
J Clin Med. 2023 May 24;12(11):3650. doi: 10.3390/jcm12113650.
Global predictions indicate that the incidence of retinopathy of prematurity (ROP) is increasing, but the lack of current epidemiological data on the occurrence of ROP in Europe prompted the authors to update these data.
European studies related to the presence of ROP were analyzed, and the reason for the differences in the percentage of ROP and different screening criteria were checked.
The study presents results from individual and multiple centers. Current ROP incidence data varies from a low of 9.3% in Switzerland to the highest values of 64.1% in Portugal and 39.5% in Norway. The national screening criteria are used in the Netherlands, Germany, Norway, Poland, Portugal, Switzerland, and Sweden. Uniform criteria-Royal College of Paediatrics and Child Health guidelines are used in England and Greece. American Academy of Pediatrics screening guidelines are used in France and Italy.
The epidemiology of ROP in European countries varies significantly. The increase in the diagnosis and treatment rate of ROP in recent years correlates with the narrowing of diagnostic criteria in newly issued guidelines (which include the WINROP and G-ROP algorithms), a higher number of less developed preterm infants, and a lower percentage of live births.
全球预测表明早产儿视网膜病变（ROP）的发病率正在上升，但目前缺乏欧洲ROP发病情况的流行病学数据，促使作者更新这些数据。
分析了与ROP存在相关的欧洲研究，并检查了ROP百分比差异和不同筛查标准的原因。
该研究展示了来自单个和多个中心的结果。目前ROP发病率数据从瑞士的低至9.3%到葡萄牙的最高值64.1%以及挪威的39.5%不等。荷兰、德国、挪威、波兰、葡萄牙、瑞士和瑞典采用国家筛查标准。英国和希腊采用统一标准——皇家儿科学会和儿童健康指南。法国和意大利采用美国儿科学会筛查指南。
欧洲国家ROP的流行病学差异显著。近年来ROP诊断和治疗率的增加与新发布指南（包括WINROP和G-ROP算法）中诊断标准的缩小、欠发达早产儿数量的增加以及活产百分比的降低相关。
